1. Product title:Fasoracetam
Fasoracetam (NS-105, 5-oxo-D-prolinepiperidinamide monohydrate) is a research chemical of the racetam family. It is a nootropic, and has been in a clinical trial for attention deficit hyperactivity disorder.
In in vitro studies on mouse neurons, fasoracetam modulated mGluR II/III activity. In studies in rats, it blocked memory disruptions caused by baclofen, a GABAB agonist and upregulated production of GABAB receptors after repeat dosing.
2. Product parameter table:
1. Fasoracetam is a research compound and member of the racetam family of nootropics,primarily known for their cognitive enhancing abilities. Fasoracetam is also an anxiolytic and may be able to improve mood as well. This racetam works by affecting three receptors within the brain: acetylcholine,GABA and glutamate, all of three of which are involved in the creation and retention of memories.
2. It is now a nootropic smart drug which portrays itself in one of the most powerful racetams in the nootropic universe. Made from a class of compounds called the racetams, and acting on not only acetylcholine but also GABA receptors in the brain, this has the ability of activating both cholinergic and glutamate receptors of the cerebral cortex, and is a revolutionary racetam drug due to its extremely unique mechanism of action. Fasoracetam currently also shows benefits as an anti-depressant, ADHD stimulant, and an anxiolytic, it also, as proven in laboratories across the nation, helps with the formation and retention of new memories.
3. Fasoracetam has also been observed to block the amnestic effects of scopolamine in a rat model of cholinergic dysfunction, which was noted as an increase of both ACh release in the cerebral cortex, as well as HACU enhancement in both the cerebral cortex and hippocampus. ChAT activity remained unaffected. In the same study, Fasoracetam was able to reverse baclofen-induced memory disruption, thus suggesting a blocking role at the GABAB receptor.
Like many of the nootropics, this member of the racetam family has been studied in controlled settings and there does appear to be a distinct benefit to patients of diseases and conditions that affect the brain and memory. Fasoracetam has proven to show benefit for people suffering from conditions like schizophrenia (Froestl, Muhs and Pfeifer 793). However, there are other studies that show that the greatest benefit of Fasoracetam can be seen in patients with Alzheimer's Disease, helping to reduce the expected loss of mental acuity and memory. Presently, there are more studies being done to determine if Fasoracetam may be a beneficial treatment for some of the young patients who are affected by the varying degree from Attention Deficit Disorder or Attention Deficit Hyperactivity Disorder, or as they are more commonly known, ADD and ADHD.
6. Benefits of Fasoracetam:
The benefits of fasoracetam are mostly in anecdote, but there are some studies to suggest a correlation. Given that there are millions of children and adolescents using amphetamine-based ADHD medication, studies testing fasoracetam effects is a good sign. Even better, fasoracetam has made it to phase II and III of clinical trials , which could suggest a high effectiveness for this purpose. As of June 2016, the drug was still in these trials.
According to anecdotal evidence on fasoracetam benefits, the concentration and stimulation benefits are moderate. One person likened the stimulation effects to noopept and another said it was more of an energy boost than stimulation.
Aside from these focus and concentration related benefits, there is evidence for neuroprotective effects as well. One rat study showed that fasoracetam could prevent memory disruptions. This is common amongst the racetam line of drugs and makes sense that fasoracetam would display many of these same properties.
Another interesting benefit of fasoracetam is as an antidepressant and anxiolytic. A study of rats with learned helplessness showed that the drug had potent antidepressant effects without some of the side effects (such as MAOI interactions). This study concluded that GABA (B) up-regulation was able to increase test results in the animals.
6. Pictures of the product: